Key facts
- Staidson (Beijing) Biopharmaceuticals Company (SHE: 300204) is a other based in Beijing, China.
About Staidson (Beijing) Biopharmaceuticals Company (SHE: 300204)
Staidson (Beijing) Biopharmaceuticals Company is a corporation based in Beijing, China. Established in 2002, the company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin. The assets are managed by the executive management team.
Free account
See more of the book
- ·Watchlist + alerts for Staidson (Beijing) Biopharmaceuticals Company (SHE: 300204)'s activity
Create free account
No card required
Portfolio
Portfolio — not yet on record
No portfolio companies for Staidson (Beijing) Biopharmaceuticals Company (SHE: 300204) are on record yet. Positions surface from round participations, filings, and coverage.
Pro members can request priority coverage with a 48-hour turnaround.
Frequently asked
- What is Staidson (Beijing) Biopharmaceuticals Company (SHE: 300204)'s AUM?
- Staidson (Beijing) Biopharmaceuticals Company (SHE: 300204) manages approximately $118 in assets.